Abstract
Cell surface carbohydrates play significant roles in a number of biologically important processes. Heparan sulfate, for instance, is a ubiquitously distributed polysulfated polysaccharide that is involved, among other things, in the initial step of herpes simplex virus type 1 (HSV-1) infection. The virus interacts with cell-surface heparan sulfate to facilitate host-cell attachment and entry. 3-O-Sulfonated heparan sulfate has been found to function as an HSV-1 entry receptor. Achieving a complete understanding of these interactions requires the chemical synthesis of such oligosaccharides, but this remains challenging. Here, we present a convenient approach for the synthesis of two irregular 3-O-sulfonated heparan sulfate octasaccharides, making use of a key disaccharide intermediate to acquire different building blocks for the oligosaccharide chain assembly. Despite substantial structural differences, the prepared 3-O-sulfonated sugars blocked viral infection in a dosage-dependent manner with remarkable similarity to one another.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Hacker, U., Nybakken, K. & Perrimon, N. Heparan sulphate proteoglycans: the sweet side of development. Nat. Rev. Mol. Cell. Biol. 6, 530–541 (2005).
Whitelock, J. M. & Iozzo, R. V. Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105, 2745–2764 (2005).
Liu, H., Zhang, Z. & Linhardt, R. J. Lessons learned from the contamination of heparin. Nat. Prod. Rep. 26, 313–321 (2009).
Esko, J. D. & Lindahl, U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108, 169–173 (2001).
Peterson, S., Frick, A. & Liu, J. Design of biologically active heparan sulfate and heparin using an enzyme-based approach. Nat. Prod. Rep. 26, 610–627 (2009).
Bishop, J. R., Schuksz, M. & Esko, J. D. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 446, 1030–1037 (2007).
Spear, P. G. Herpes simplex virus: receptors and ligands for cell entry. Cell. Microbiol. 6, 401–410 (2004).
Sedy, J. R., Spear, P. G. & Ware, C. F. Cross-regulation between herpes viruses and the TNF superfamily members. Nat. Rev. Immunol. 8, 861–873 (2008).
Liu, J. & Thorp, S. C. Cell surface heparan sulfate and its roles in assisting viral infections. Med. Res. Rev. 22, 1–25 (2002).
Shieh, M., WuDunn, D., Montgomery, R., Esko, J. & Spear, P. Cell surface receptors for herpes simplex virus are heparan sulfate proteoglycans. J. Cell Biol. 116, 1273–1281 (1992).
Oh, M-J., Akhtar, J., Desai, P. & Shukla, D. A role for heparan sulfate in viral surfing. Biochem. Biophys. Res. Commun. 391, 176–181 (2010).
Spear, P. G., Eisenberg, R. J. & Cohen, G. H. Three classes of cell surface receptors for alphaherpesvirus entry. Virology 275, 1–8 (2000).
Shukla, D. et al. A novel role for 3-O-sulfated heparan sulfate in herpes simplex virus 1 entry. Cell 99, 13–22 (1999).
Akhtar, J. & Shukla, D. Viral entry mechanisms: cellular and viral mediators of herpes simplex virus entry. FEBS J. 276, 7228–7236 (2009).
Campadelli-Fiume, G. et al. The multipartite system that mediates entry of herpes simplex virus into the cell. Rev. Med. Virol. 17, 313–326 (2007).
Reske, A., Pollara, G., Krummenacher, C., Chain, B. M. & Katz, D. R. Understanding HSV-1 entry glycoproteins. Rev. Med. Virol. 17, 205–215 (2007).
Liu, J. et al. Characterization of a heparan sulfate octasaccharide that binds to herpes simplex virus type 1 glycoprotein D. J. Biol. Chem. 277, 33456–33467 (2002).
Copeland, R. et al. Using a 3-O-sulfated heparin octasaccharide to inhibit the entry of herpes simplex virus type 1. Biochemistry 47, 5774–5783 (2008).
Petitou, M. & van Boeckel, C. A. A. A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next? Angew. Chem. Int. Ed. 42, 3118–3133 (2004).
de Paz, J. L. et al. The activation of fibroblast growth factors by heparin: synthesis, structure, and biological activity of heparin-like oligosaccharides. ChemBioChem 2, 673–685 (2001).
Laremore, T. N., Zhang, F., Dordick, J. S., Liu, J. & Linhardt, R. J. Recent progress and applications in glycosaminoglycan and heparin research. Curr. Opin. Chem. Biol. 13, 633–640 (2009).
Hung, S-C. et al. 1,6-anhydro-β-L-hexopyranoses as potent synthons in the synthesis of the disaccharide units of bleomycin A2 and heparin. J. Am. Chem. Soc. 123, 3153–3154 (2001).
Lee, J-C. et al. From D-glucose to biologically potent L-hexose derivatives: synthesis of α-L-iduronidase fluorogenic detector and the disaccharide moieties of bleomycin A2 and heparan sulfate. Chem. Eur. J. 10, 399–415 (2004).
Codée, J. D. C. et al. A modular strategy toward the synthesis of heparin-like oligosaccharides using monomeric building blocks in a sequential glycosylation strategy. J. Am. Chem. Soc. 127, 3767–3773 (2005).
Noti, C., de Paz, J. L., Polito, L. & Seeberger, P. H. Preparation and use of microarrays containing synthetic heparin oligosaccharides for the rapid analysis of heparin–protein interactions. Chem. Eur. J. 12, 8664–8686 (2006).
Baleux, F. et al. A synthetic CD4–heparan sulfate glycoconjugate inhibits CCR5 and CXCR4 HIV-1 attachment and entry. Nat. Chem. Biol. 5, 743–748 (2009).
Arungundram, S. et al. Modular synthesis of heparan sulfate oligosaccharides for structure–activity relationship studies. J. Am. Chem. Soc. 131, 17394–17405 (2009).
Lu, L-D. et al. Synthesis of 48 disaccharide building blocks for the assembly of a heparin and heparan sulfate oligosaccharide library. Org. Lett. 8, 5995–5998 (2006).
Lohman, G. J. S. & Seeberger, P. H. A stereochemical surprise at the late stage of the synthesis of fully N-differentiated heparin oligosaccharides containing amino, acetamido, and N-sulfonate groups. J. Org. Chem. 69, 4081–4093 (2004).
Wang, C-C. et al. Regioselective one-pot protection of carbohydrates. Nature 446, 896–899 (2007).
Wang, C-C., Kulkarni, S. S., Lee, J-C., Luo, S-Y. & Hung, S-C. Regioselective one-pot protection of glucose. Nat. Protoc. 3, 97–113 (2008).
Chang, K-L., Zulueta, M. M. L., Lu, X-A., Zhong, Y-Q. & Hung, S-C. Regioselective one-pot protection of D-glucosamine. J. Org. Chem. 75, 7424–7427 (2010).
Lee, J-C., Lu, X-A., Kulkarni, S. S., Wen, Y-S. & Hung, S-C. Synthesis of heparin oligosaccharides. J. Am. Chem. Soc. 126, 476–477 (2004).
Plante, O. J., Buchwald, S. L. & Seeberger, P. H. Halobenzyl ethers as protecting groups for organic synthesis. J. Am. Chem. Soc. 122, 7148–7149 (2000).
Kulkarni, S. S. & Hung, S-C. Metal tifluoromethanesulfonates as versatile catalysts in carbohydrate synthesis. Lett. Org. Chem. 2, 670–677 (2005).
van den Berg, R. J. B. H. N., Noort, D., van der Marel, G. A., van Boom, J. H., Benschop, H. P. Synthesis of pseudo-disaccharide analogues of Lipid A: haptens for the generation of antibodies with glycosidase activity towards Lipid A. J. Carbohydr. Chem. 21, 167–168 (2002).
Warner, M. S. et al. A cell surface protein with herpesvirus entry activity (HveB) confers susceptibility to infection by mutants of herpes simplex virus type 1, herpes simplex virus type 2, and pseudorabies virus. Virology 246, 179–189 (1998).
Acknowledgements
This work was supported by the National Science Council (NSC 97-2113-M-001-033-MY3, NSC 98-2119-M-001-008-MY2) and Academia Sinica. The authors thank P.G. Spear for providing HSV-1 (KOS) tk12.
Author information
Authors and Affiliations
Contributions
S-C.H. conceived the idea of HS synthesis, supervised students to carry out the experiments, drew and summarized the figures, and finalized the preparation of the manuscript. Y-P.H. and S-Y.L. synthesized the irregular HS octasaccharides 3 and 4, respectively. C-Y.H. carried out the inhibition experiments of HSV-1 with Vero cells. M.M.L.Z. participated in the discussion and wrote the manuscript. J-Y.L. initiated the work on the preparation of the oligosaccharide skeleton. W.C. supervised C-Y.H. on the inhibition study of HSV-1 infection.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary information
Supplementary information (PDF 9384 kb)
Rights and permissions
About this article
Cite this article
Hu, YP., Lin, SY., Huang, CY. et al. Synthesis of 3-O-sulfonated heparan sulfate octasaccharides that inhibit the herpes simplex virus type 1 host–cell interaction. Nature Chem 3, 557–563 (2011). https://doi.org/10.1038/nchem.1073
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchem.1073
This article is cited by
-
Heparanase is the possible link between monkeypox and Covid-19: robust candidature in the mystic and present perspective
AMB Express (2023)
-
Efficient platform for synthesizing comprehensive heparan sulfate oligosaccharide libraries for decoding glycosaminoglycan–protein interactions
Nature Chemistry (2023)
-
Silver-assisted gold-catalyzed formal synthesis of the anticoagulant Fondaparinux pentasaccharide
Communications Chemistry (2021)
-
Comparative study of serum zinc concentration in recurrent herpes labialis patients and healthy individuals
BMC Oral Health (2020)
-
Glycan sulfation patterns define autophagy flux at axon tip via PTPRσ-cortactin axis
Nature Chemical Biology (2019)